Published in Mol Ther on June 02, 2016
Knockdown of long non-coding RNA XIST increases blood-tumor barrier permeability and inhibits glioma angiogenesis by targeting miR-137. Oncogenesis (2017) 0.75
Transcription Factor NFAT5 Promotes Glioblastoma Cell-driven Angiogenesis via SBF2-AS1/miR-338-3p-Mediated EGFL7 Expression Change. Front Mol Neurosci (2017) 0.75
MicroRNAs: genomics, biogenesis, mechanism, and function. Cell (2004) 198.59
MicroRNA signatures in human cancers. Nat Rev Cancer (2006) 46.29
Evolution and functions of long noncoding RNAs. Cell (2009) 17.54
The functional role of long non-coding RNA in human carcinomas. Mol Cancer (2011) 6.37
The emergence of lncRNAs in cancer biology. Cancer Discov (2011) 6.32
A genome-wide association study of psoriasis and psoriatic arthritis identifies new disease loci. PLoS Genet (2008) 5.85
Exciting new advances in neuro-oncology: the avenue to a cure for malignant glioma. CA Cancer J Clin (2010) 5.53
MTDH activation by 8q22 genomic gain promotes chemoresistance and metastasis of poor-prognosis breast cancer. Cancer Cell (2009) 4.47
Metadherin, a cell surface protein in breast tumors that mediates lung metastasis. Cancer Cell (2004) 3.09
Long noncoding RNAs and the genetics of cancer. Br J Cancer (2013) 2.98
Activation of the nuclear factor kappaB pathway by astrocyte elevated gene-1: implications for tumor progression and metastasis. Cancer Res (2006) 2.60
Astrocyte elevated gene-1 activates cell survival pathways through PI3K-Akt signaling. Oncogene (2007) 2.51
Astrocyte elevated gene-1 (AEG-1) functions as an oncogene and regulates angiogenesis. Proc Natl Acad Sci U S A (2009) 2.10
RUNX genes in development and cancer: regulation of viral gene expression and the discovery of RUNX family genes. Adv Cancer Res (2008) 2.04
A miRNA signature of prion induced neurodegeneration. PLoS One (2008) 1.96
The microRNA miR-139 suppresses metastasis and progression of hepatocellular carcinoma by down-regulating Rho-kinase 2. Gastroenterology (2010) 1.85
Astrocyte elevated gene-1: recent insights into a novel gene involved in tumor progression, metastasis and neurodegeneration. Pharmacol Ther (2007) 1.80
Candidate microRNA biomarkers in human colorectal cancer: systematic review profiling studies and experimental validation. Int J Cancer (2011) 1.46
Astrocyte elevated gene-1: a novel target for human glioma therapy. Mol Cancer Ther (2010) 1.39
MiR-139 inhibits invasion and metastasis of colorectal cancer by targeting the type I insulin-like growth factor receptor. Biochem Pharmacol (2012) 1.36
Oncofetal H19 RNA promotes tumor metastasis. Biochim Biophys Acta (2014) 1.35
Knockdown of long non-coding RNA XIST exerts tumor-suppressive functions in human glioblastoma stem cells by up-regulating miR-152. Cancer Lett (2015) 1.26
miR-139-5p is a regulator of metastatic pathways in breast cancer. RNA (2013) 1.25
Long non-coding RNA CASC2 suppresses malignancy in human gliomas by miR-21. Cell Signal (2014) 1.24
Runx1 directly promotes proliferation of hair follicle stem cells and epithelial tumor formation in mouse skin. Mol Cell Biol (2010) 1.23
C-Myc-activated long noncoding RNA CCAT1 promotes colon cancer cell proliferation and invasion. Tumour Biol (2014) 1.19
Role of MYC-regulated long noncoding RNAs in cell cycle regulation and tumorigenesis. J Natl Cancer Inst (2015) 1.13
The RUNX1 transcription factor is expressed in serous epithelial ovarian carcinoma and contributes to cell proliferation, migration and invasion. Cell Cycle (2013) 1.08
Noncoding RNA in oncogenesis: a new era of identifying key players. Int J Mol Sci (2013) 1.03
MiR-139 targets CXCR4 and inhibits the proliferation and metastasis of laryngeal squamous carcinoma cells. Med Oncol (2013) 1.01
Posttranslational modifications of RUNX1 as potential anticancer targets. Oncogene (2014) 1.00
MiR-139 inhibits Mcl-1 expression and potentiates TMZ-induced apoptosis in glioma. CNS Neurosci Ther (2013) 1.00
Antiangiogenic therapy for high-grade glioma. Cochrane Database Syst Rev (2014) 0.97
Astrocyte elevated gene-1 interacts with β-catenin and increases migration and invasion of colorectal carcinoma. Mol Carcinog (2012) 0.96
The long noncoding RNA TUG1 regulates blood-tumor barrier permeability by targeting miR-144. Oncotarget (2015) 0.95
The long non-coding RNA ERIC is regulated by E2F and modulates the cellular response to DNA damage. Mol Cancer (2013) 0.93
Runx family genes, niche, and stem cell quiescence. Blood Cells Mol Dis (2010) 0.92
Noncoding RNAs in cancer and cancer stem cells. Chin J Cancer (2013) 0.92
Pleiotropic roles of AEG-1/MTDH/LYRIC in breast cancer. Adv Cancer Res (2013) 0.91
Uncontrolled inflammation induced by AEG-1 promotes gastric cancer and poor prognosis. Cancer Res (2014) 0.90
Astrocyte elevated gene-1(AEG-1) induces epithelial-mesenchymal transition in lung cancer through activating Wnt/β-catenin signaling. BMC Cancer (2015) 0.88
Runx1 contributes to neurofibromatosis type 1 neurofibroma formation. Oncogene (2015) 0.87
Comparative genetic analyses point to HCP5 as susceptibility locus for HCV-associated hepatocellular carcinoma. J Hepatol (2013) 0.87
MiR-145 acts as a metastasis suppressor by targeting metadherin in lung cancer. Med Oncol (2014) 0.84
Involvement of aberrant miR-139/Jun feedback loop in human gastric cancer. Biochim Biophys Acta (2014) 0.83
Circulating microRNA biomarkers for glioma and predicting response to therapy. Mol Neurobiol (2014) 0.82
miR-139-5p suppresses cancer cell migration and invasion through targeting ZEB1 and ZEB2 in GBM. Tumour Biol (2015) 0.78
A potential diagnostic marker for ovarian cancer: Involvement of the histone acetyltransferase, human males absent on the first. Oncol Lett (2013) 0.78